Effect of pharmacological treatment for urinary incontinence in the elderly and frail elderly: A systematic review
- 5 February 2015
- journal article
- review article
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 15 (5) , 521-534
Abstract
Aim: The prevalence and severity of urinary incontinence (UI) increase with age and comorbidity. The benefits of pharmacotherapy for UI in the elderly are questionable. The aim of the present study was to systematically review the efficacy of pharmacological treatment for UI in the elderly and frail elderly.Methods: We searched PubMed, EMBASE, Cochrane library and Cinahl databases through October 2013 to identify prospective controlled trials that evaluated pharmacological treatment for UI in persons aged ≥65 years. Elderly persons living in nursing homes were regarded as frail elderly. Outcomes were urinary leakage, quality of life and adverse events.Results: We screened 1038 abstracts and assessed 309 full‐text articles. We identified 13 trials of high or moderate quality; 11 evaluated anticholinergic drugs and two evaluated duloxetine. Oxybutynin, the only drug studied in the frail elderly population, had no effect on urinary leakage or quality of life in elderly with urgency UI (UUI). Seven trials evaluated the effects of darifenacin, fesoterodine, solifenacin, tolterodine or trospium. Urinary leakage decreased (standard mean difference: −0.24, 95% confidence interval −0.32–0.15), corresponding to a reduction of half a leakage per 24 h. Common side‐effects of treatment were dry mouth and constipation. Data were insufficient for evaluation of the effect on quality of life or cognition. The evidence was insufficient to evaluate the effects of duloxetine. No eligible studies on mirabegron and estrogen were found.Conclusions: Anticholinergics have a small, but significant, effect on urinary leakage in older adults with UUI. Treatment with drugs for UUI in the frail elderly is not evidence based. Geriatr Gerontol Int 2015; 15: 521–534.Keywords
Funding Information
- Swedish Council on Technology Assessment in Health Care (SBU)
This publication has 37 references indexed in Scilit:
- Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: A post hoc, pooled analysis from two placebo‐controlled trialsNeurourology and Urodynamics, 2012
- Frailty Defined by Deficit Accumulation and Geriatric Medicine Defined by FrailtyClinics in Geriatric Medicine, 2011
- Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndromeBJU International, 2010
- Patient‐reported reasons for discontinuing overactive bladder medicationBJU International, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Randomized, Placebo‐Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended‐Release Oxybutynin in Cognitively Impaired Nursing Home Residents with Urge Urinary IncontinenceJournal of the American Geriatrics Society, 2008
- Dual Use of Bladder Anticholinergics and Cholinesterase Inhibitors: Long‐Term Functional and Cognitive OutcomesJournal of the American Geriatrics Society, 2008
- Treatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin, an M3 Selective Receptor AntagonistEuropean Urology, 2005
- A community-based epidemiological survey of female urinary incontinence:Journal of Clinical Epidemiology, 2000
- Oxybutynin with Bladder Retraining for Detrusor Instability in Elderly People: A Randomized Controlled TrialAge and Ageing, 1995